(Q73186293)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9084896%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Plasma free 3-methoxy-4-hydroxyphenylglycol predicts response to fluoxetine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9084896%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

Ko HC

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9084896%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Lu RB

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9084896%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Shiah IS

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9084896%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Hwang CC

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9084896%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 April 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9084896%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

Biological Psychiatry

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9084896%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9084896%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9084896%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

774-781

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9084896%20AND%20SRC:MED&resulttype=core&format=json

Characteristics of patients with the highest plasma catecholamine metabolite levels.

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900207-7

A diagnostic interview: the schedule for affective disorders and schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900207-7

Does 24-h urinary MHPG predict treatment response to antidepressants? I. A review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900207-7

Development of a Rating Scale for Primary Depressive Illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900207-7

Failure of urinary MHPG levels to predict treatment response in patients with unipolar depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900207-7

Relation between plasma and cerebrospinal fluid levels of 3-methoxy-4-hydroxyphenylglycol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900207-7

Disposition and Metabolism of MHPG in Humans: Application to Studies in Depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900207-7

Catecholamine Metabolism, Depressive Illness, and Drug Response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900207-7

3-Methoxy-4-Hydroxyphenethyleneglycol Production by Human Brain in Vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900207-7

Pretreatment neurotransmitter metabolite levels and response to tricyclic antidepressant drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900207-7

Blockade of noradrenaline uptake by 34276-Ba, a new antidepressant drug

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900207-7

Plasma-free and sulfoconjugated MHPG in major depressive disorders: differences between responders to treatment and nonresponders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900207-7

Determination of free 3-methoxy-4-hydroxyphenylglycol with several other monoamine metabolites in plasma by high-performance liquid chromatography with amperometric detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900207-7

Disruption of circadian MHPG rhythmicity in major depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900207-7

MHPG as a predictor of antidepressant response to imipramine and maprotiline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900207-7

Toward a biochemical classification of depressive disorders. III: Pretreatment urinary MHPG levels as predictors of response to treatment with maprotiline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900207-7

Norepinephrine metabolites as biochemical criteria for classifying depressive disorders and predicting responses to treatment: preliminary findings.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900207-7

Denosologization of biological psychiatry or the specificity of 5-HT disturbances in psychiatric disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900207-7

Noradrenergic and serotoninergic depression?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900207-7

10.1016/S0006-3223(96)00207-7

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9084896%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference